Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Accounts Payables (2016 - 2026)

Champions Oncology (CSBR) has 15 years of Accounts Payables data on record, last reported at $6.0 million in Q4 2025.

  • For Q4 2025, Accounts Payables rose 23.47% year-over-year to $6.0 million; the TTM value through Oct 2025 reached $6.0 million, up 23.47%, while the annual FY2025 figure was $4.2 million, 26.76% down from the prior year.
  • Accounts Payables reached $6.0 million in Q4 2025 per CSBR's latest filing, up from $4.8 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $6.0 million in Q4 2025 and bottomed at $1.7 million in Q1 2021.
  • Average Accounts Payables over 5 years is $4.2 million, with a median of $4.6 million recorded in 2022.
  • Peak YoY movement for Accounts Payables: plummeted 39.68% in 2021, then soared 127.0% in 2023.
  • A 5-year view of Accounts Payables shows it stood at $3.5 million in 2021, then skyrocketed by 32.44% to $4.6 million in 2022, then fell by 1.5% to $4.5 million in 2023, then increased by 7.01% to $4.9 million in 2024, then rose by 23.47% to $6.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accounts Payables were $6.0 million in Q4 2025, $4.8 million in Q3 2025, and $4.2 million in Q2 2025.